Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
News Medical on MSN
Leukemia That Starts Before Birth Is More Aggressive
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...
Investor's Business Daily on MSN
Stocks to watch: CRISPR Therapeutics sees relative strength rating rise to 82
CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback